Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -71.04% is 98% below its 5-year average of -35.84%, near the low end of its 5-year range (-71.04%–4.63%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.83% below its 12-month average of -61.33%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -71.04%.
RETURN ON INVESTED CAPITAL (ROIC)
-71.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-61.33%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-47.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-35.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.83%
CURRENT VS 3Y AVG
-50.20%
CURRENT VS 5Y AVG
-98.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-99.22%
vs the sector median at left
Alector, Inc.
Market Cap
$200.96M
Return on Invested Capital (ROIC)
-71.04%
TTM Avg
-61.33%
3Y Avg
-47.30%
5Y Avg
-35.84%
Market Cap
$198.33M
Return on Invested Capital (ROIC)
-33.10%
TTM Avg
-20.50%
3Y Avg
-16.94%
5Y Avg
-23.40%
Market Cap
$197.87M
Return on Invested Capital (ROIC)
-33.88%
TTM Avg
-37.38%
3Y Avg
-46.28%
5Y Avg
-37.99%
Market Cap
$197.18M
Return on Invested Capital (ROIC)
-41.61%
TTM Avg
-54.73%
3Y Avg
-70.67%
5Y Avg
-64.43%
Market Cap
$205.80M
Return on Invested Capital (ROIC)
-47.05%
TTM Avg
-105.31%
3Y Avg
-79.09%
5Y Avg
-78.87%
Market Cap
$207.27M
Return on Invested Capital (ROIC)
14.99%
TTM Avg
15.04%
3Y Avg
13.17%
5Y Avg
12.12%
Market Cap
$208.31M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$192.49M
Return on Invested Capital (ROIC)
-20.24%
TTM Avg
-14.71%
3Y Avg
-27.01%
5Y Avg
-29.46%
Market Cap
$209.91M
Return on Invested Capital (ROIC)
26.14%
TTM Avg
3.79%
3Y Avg
-12.27%
5Y Avg
-17.37%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alector, Inc. (ALEC) | $200.96M | -71.04% | -61.33% | -47.30% | -35.84% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $198.33M | -33.10% | -20.50% | -16.94% | -23.40% |
| Exagen Inc. (XGN)vs › | $197.87M | -33.88% | -37.38% | -46.28% | -37.99% |
| Surrozen, Inc. (SRZN)vs › | $197.18M | -41.61% | -54.73% | -70.67% | -64.43% |
| Whitehawk Therapeutics Inc (WHWK)vs › | $205.80M | -47.05% | -105.31% | -79.09% | -78.87% |
| Pro-Dex, Inc. (PDEX)vs › | $207.27M | 14.99% | 15.04% | 13.17% | 12.12% |
| Electra Therapeutics Inc. (ETRA)vs › | $208.31M | N/A | N/A | N/A | N/A |
| RxSight, Inc. (RXST)vs › | $192.49M | -20.24% | -14.71% | -27.01% | -29.46% |
| Compugen Ltd. (CGEN)vs › | $209.91M | 26.14% | 3.79% | -12.27% | -17.37% |
| Entrada Therapeutics, Inc. (TRDA)vs › | $210.41M | -63.61% | -17.34% | -19.38% | -26.83% |
ROIC
-71.0%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -71.04% |
| 2026-03-31 | -68.12% |
| 2025-12-31 | -69.61% |
| 2025-09-30 | -48.44% |
| 2025-06-30 | -49.44% |
| 2025-03-31 | -48.90% |
| 2024-12-31 | -42.24% |
| 2024-09-30 | -49.59% |
| 2024-06-30 | -44.29% |
| 2024-03-31 | -30.88% |
| 2023-12-31 | -34.18% |
| 2023-09-30 | -30.90% |
| 2023-06-30 | -27.22% |
| 2023-03-31 | -21.89% |
| 2022-12-31 | -19.87% |
| 2022-09-30 | -20.43% |
| 2022-06-30 | 4.63% |
| 2022-03-31 | -3.55% |
| 2021-12-31 | -5.53% |
| 2021-09-30 | -4.77% |
| 2021-06-30 | -66.46% |
| 2021-03-31 | -54.67% |
| 2020-12-31 | -46.45% |
| 2020-09-30 | -37.95% |
| 2020-06-30 | -30.65% |
| 2020-03-31 | -24.80% |
| 2019-12-31 | -31.78% |
| 2019-09-30 | -25.85% |
| 2019-06-30 | -20.42% |
| 2019-03-31 | -15.63% |
| 2018-12-31 | -19.40% |
| 2018-09-30 | -17.31% |
| 2018-06-30 | -17.38% |
| 2017-12-31 | -15.66% |
